|
A first-chair litigator and trial lawyer, Tony Herman has tried to verdict more than 20 cases, jury and non-jury, in federal and state courts and before arbitration panels throughout the US. His broad ranging litigation, arbitration and trial practice, often on behalf of pharmaceutical companies, focuses on intellectual property litigation, including patent and trade secret litigation, FDA litigation, and general commercial litigation. He has been in charge of large, complex litigation matters for companies such as Pfizer, Johnson & Johnson, Merck, Schering-Plough, and Wyeth.
Representative Matters
- Represented Northrop Grumman in four-week trade secrets jury trial in Maryland state court where plaintiff sought more than $100 million in damages.
- Represented GPC Biotech in ICDR arbitration resulting in complete defense victory for client in licensing dispute where licensor sought termination of license agreement and tens of millions of dollars in damages.
- Represented semi-conductor company in six week jury trial in federal district court in New Jersey.
- Represented Merck in obtaining injunction against FDA.
- Represented Pfizer in FDA litigation upholding grant of pediatric exclusivity.
- Represented Johnson & Johnson in FDA litigation upholding grant of pediatric exclusivity.
- Represented Schering Plough and Wyeth in Hatch Waxman patent litigation.
Previous Experience
- Florida State University College of Law, Assistant Professor of Law (1987-1989)
Honors and Rankings
- Who’s Who in American Law (1998-)
- Recognized as a leading lawyer by Legal 500 US in their “IP: Contentious - Trade Secrets - Integrated Service, Advice and Litigation” category (2007).
Memberships and Affiliations
- Bread for the City, Board of Directors (2003-)
- Washington Lawyers’ Committee for Civil Rights and Urban Affairs, Board of Trustees (2004-)
- Washington Legal Clinic For The Homeless, Board of Directors (2007-)
Publications and Speeches
- E-Commerce Law & Business, Contributor on trade secret litigation
- The Contingent Workforce, Co-Author
|